Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spain investigates obesity surgery safety:

This article was originally published in Clinica

Executive Summary

The Spanish health ministry has launched an enquiry into the use of surgical treatments of morbid obesity, amid safety concerns. Almost 3,000 cases were diagnosed in 2002, of which 1,500 underwent surgery, most commonly gastric bypass. Of these patients, 15 (1%) died, according to the health ministry. But Spanish experts believe that 10% of cases suffer serious complications, with mortality rising to 2%. At least seven deaths have been recorded this year. Some 1.5% of Spaniards are morbidly obese (defined as a body mass index of over 40, when a normal weight is an index of 25), according to the national society for the study of obesity (SEEO), which believes that the number of diagnoses is currently rising by around 50% a year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT057696

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel